Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hypertrophy, Left Ventricular

• A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software
• Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
• Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy
• Effect of Dapagliflozin on Myocardial and Renal Function Following Aortic Valve Stenosis Intervention
• Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.
• Empagliflozin and Cardiac Remodelling in People Without Diabetes
• LCZ696 in Advanced LV Hypertrophy and HFpEF
• Imaging Histone Deacetylase in the Heart
• Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal Transplants
• Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study
• Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy
• Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVH
• Diffusion MRI in Heart Failure
• Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes?
• Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart Failure
• Effects of Everolimus in Left Ventricular Hypertrophy After Conversion From Azathioprine: A Pilot Study
• Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension?
• MetfoRmin and Its Effects on Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery Disease
• Effect of Isosorbide Mononitrate on Hypertension to Improve Left Ventricular Hypertrophy, Fibrosis and Myocardial Function
• Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study
• Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy
• REmodelling in Diabetic CardiOmapathy: Gender Response to PDE5i InhibiTOrs
• Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy
• Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction(HFpEF)
• Effects of Levosimendan in Patients Eligible for Aortic Valve Replacement With Left Ventricular Hypertrophy
• Stenting of Renal Artery Stenosis in Coronary Artery Disease Study
• Glutamate and Diastolic Function in Patients Undergoing Aortic Valve Repair
• Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy
• Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis
• Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168)
• Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction?
• The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5
• Attenuation of Cardiac Effects of Arteriovenous Fistula Creation With Losartan
• Hypertension in Hemodialysis Patients (Aim 3)
• Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
• Left Ventricular Hypertrophy and Spironolactone in End Stage Renal Disease
• Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression
• The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4
• Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy
• A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects.
• I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy
• Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)
• Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133)
• Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis
• Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension
• Active Vitamin D Effect on Left Ventricular Hypertrophy
• Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension
• The CLEVER Study - Coreg And Left Ventricular Mass Regression
• The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling
• Long Term Effects of Enalapril and Losartan on Genetic Heart Disease